Supplemental material
Cell Cycle
Volume 18, 2019 - Issue 2
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Cyp24a1 Attenuation Limits Progression of BrafV600E -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720.
Source:
American Association for Cancer Research (AACR)
LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.
Source:
Impact Journals, LLC
LncRNA-SLC6A9-5:2: A potent sensitizer in 131I-resistant papillary thyroid carcinoma with PARP-1 induction.
Source:
Impact Journals, LLC
Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway
Source:
Taylor & Francis
MicroRNA-384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACB
Source:
Hindawi Limited
Expression of Endogenous Oncogenic V600EB-raf Induces Proliferation and Developmental Defects in Mice and Transformation of Primary Fibroblasts
Source:
American Association for Cancer Research (AACR)
Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
Source:
Springer Science and Business Media LLC
PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway
Source:
Spandidos Publications
LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells.
Source:
Elsevier BV
Identification of pivotal lncRNAs in papillary thyroid cancer using lncRNA-mRNA-miRNA ceRNA network analysis.
Source:
PeerJ
A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains
Source:
Springer Science and Business Media LLC
LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer
Source:
Elsevier BV
Clinical outcome in differentiated thyroid carcinoma and microcarcinoma
Source:
Elsevier BV
STAT3-induced up-regulation of lncRNA NEAT1 as a ceRNA facilitates abdominal aortic aneurysm formation by elevating TULP3.
Source:
Portland Press Ltd.
Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant.
Source:
American Association for Cancer Research (AACR)
Retracted Article: Long non-coding RNA NEAT1 accelerates cell progression in cervical cancer by regulating the miR-889-3p/E2F7 axis through the activation of the PI3K/AKT pathway
Source:
Royal Society of Chemistry (RSC)
Linking provided by
